A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer
- 1 February 2003
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 39 (2) , 215-219
- https://doi.org/10.1016/s0169-5002(02)00502-0
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: